Chainon Neurotrophin Biotechnology Inc., USA
Title: Marine Phospholipids Based Potential Brain Drugs
Su Chen (CEO at the Chainon Neurotrophin Biotechnolohy Inc, Texas USA since 2006) got his Ph..D. in Mario Negri Institute for Pharmacological Research in Milan of Italy in 1989, and was a post doctoral fellow in Italian National Research Council at Padova from 1990 - 1992. After his research position as Senior Research Fellow at Department of Chemistry of the University of Warwick in Uk from 1992-1997, he was appointed as a Faculty member in Department of Pharmacology at Rush University School of Medicine (1998-2002), and then Quest Diagnostic Nichols Institute as depatmental associate scientific director (2002-2005) in the US. He contributed significantly in areas of chemistry, biochemistry and pharmacology of marine phospholipids, particularly development of DHA - containing phospholipids for prevention and treatment of neurodegenerative disorders. He already published more than 40 articles and 3 book chapters in the fields of chemistry, biochemistry and biotechnology of lipids/bioactive lipid molecules. Su Chen now is the Secretary-General of the International Society of Dietary Supplement and Phytotherapy from 2011 - 2014.